Completed OBSERVATIONAL NCT03727308

Study of Clinic-based Versus Self-use of Medical Abortion Pills (MOC)

A Prospective, Comparative Study of Clinical Outcomes Following Clinic-based Versus Self-use of Medical Abortion Using Mifepristone With Misoprostol

Sponsor: Ipas

Conditions First Trimester Abortion Induced Abortion Mifepristone Misoprostol

Interventions Medical abortion pills sourced from health clinics Medical abortion pills sourced from pharmacies

Updated 8 times since 2018 Last updated: Sep 2, 2021 Started: May 30, 2018 Primary completion: Jun 2, 2021 Completion: Jun 2, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates First Trimester Abortion and Induced Abortion and is currently completed. Ipas leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Oct 2021 [monthly]

Recruiting
Jan 2021 — Mar 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Sep 2019 — Jan 2021 [monthly]

Recruiting
Apr 2019 — Sep 2019 [monthly]

Recruiting
Dec 2018 — Apr 2019 [monthly]

Recruiting

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ipas
University of Health Science, Phnom Penh, Cambodia

Data source: Ipas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Accra, Ghana
• Phnom Penh, Cambodia